Innate immune response is differentially dysregulated between bipolar disease and schizophrenia

Schizophrenia Research

Volumn 161, Issue 2-3, 2015, Pages 215-221

  de Baumont, Angelica ^a   Maschietto, Mariana ^a,b   Lima, Leandro ^b   Carraro, Dirce Maria ^b   Olivieri, Eloisa Helena ^b   Fiorini, Alex ^b   Barreta, Luiz André Nardin ^b   Palha, Joana Almeida ^c,d   Belmonte de Abreu, Paulo ^e   Moreira Filho, Carlos Alberto ^a   Brentani, Helena ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY OF MINHO   (Portugal)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bipolar disorder; Co expression; Network; Protein protein interaction (PPI); Schizophrenia

Indexed keywords

CASPASE 4; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; TOLL LIKE RECEPTOR 1; ALPHA 1 ANTITRYPSIN; CASP4 PROTEIN, HUMAN; CCR1 PROTEIN, HUMAN; CCR5 PROTEIN, HUMAN; COMPLEMENT COMPONENT C1; INITIATOR CASPASE; MEMBRANE PROTEIN; SERPINA1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROBP PROTEIN, HUMAN;

ADULT; ARTICLE; BIPOLAR DISORDER; C1QA GENE; CASP4 GENE; CCR1 GENE; CCR5 GENE; CD68 GENE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC SUSCEPTIBILITY; HCST GENE; HUMAN; HUMAN TISSUE; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PROTEIN PROTEIN INTERACTION; S100A11 GENE; SCHIZOPHRENIA; SERPINA1 GENE; TLR1 GENE; TYROBP GENE; BRAIN; DNA MICROARRAY; GENE REGULATORY NETWORK; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALPHA 1-ANTITRYPSIN; BIPOLAR DISORDER; BRAIN; CASPASES, INITIATOR; COMPLEMENT C1; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; IMMUNITY, INNATE; LINEAR MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CCR1; RECEPTORS, CCR5; SCHIZOPHRENIA;

EID: 84921538126     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.10.055     Document Type: Article

References (62)

1. Alaerts M., Del-Favero J. Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future. Hum. Mutat. 2009, 30(8):1139-1152.
2. Barnett J.H., Smoller J.W. The genetics of bipolar disorder. Neuroscience 2009, 164(1):331-343.
3. Bienvenu O.J., Davydow D.S., Kendler K.S. Psychiatric 'diseases' versus behavioral disorders and degree of genetic influence. Psychol. Med. 2011, 41(1):33-40.
4. Cai J.J., Borenstein E., Petrov D.A. Broker genes in human disease. Genome Biol. Evol. 2010, 2:815-825.
5. Cameron B., Landreth G.E. Inflammation, microglia, and alzheimer's disease. Neurobiol. Dis. 2010, 37(3):503-509.
6. Chertkow Y., Weinreb O., Youdim M.B., Silver H. Gene expression changes in peripheral mononuclear cells from schizophrenic patients treated with a combination of antipsychotic with fluvoxamine. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31(7):1356-1362.
7. Choi K.H., Elashoff M., Higgs B.W., Song J., Kim S., Sabunciyan S., Diglisic S., Yolken R.H., Knable M.B., Torrey E.F., Webster M.J. Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry 2008, 8:87.
8. Cline M.S., Smoot M., Cerami E., Kuchinsky A., Landys N., Workman C., Christmas R., Avila-Campilo I., Creech M., Gross B., Hanspers K., Isserlin R., Kelley R., Killcoyne S., Lotia S., Maere S., Morris J., Ono K., Pavlovic V., Pico A.R., Vailaya A., Wang P.L., Adler A., Conklin B.R., Hood L., Kuiper M., Sander C., Schmulevich I., Schwikowski B., Warner G.J., Ideker T., Bader G.D. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2007, 2(10):2366-2382.
9. Das J., Yu H. HINT: High-quality protein interactomes and their applications in understanding human disease. BMC Syst. Biol. 2012, 6:92.
10. Doherty J.L., O'Donovan M.C., Owen M.J. Recent genomic advances in schizophrenia. Clin. Genet. 2012, 81(2):103-109.
11. Drexhage R.C., van der Heul-Nieuwenhuijsen L., Padmos R.C., van Beveren N., Cohen D., Versnel M.A., Nolen W.A., Drexhage H.A. Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int. J. Neuropsychopharmacol. 2010, 13(10):1369-1381.
12. Eltayeb S., Berg A.L., Lassmann H., Wallstrom E., Nilsson M., Olsson T., Ericsson-Dahlstrand A., Sunnemark D. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: Insight into mechanisms of MOG-induced EAE. J. Neuroinflammation 2007, 4.
13. Feldman I., Rzhetsky A., Vitkup D. Network properties of genes harboring inherited disease mutations. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(11):4323-4328.
14. Fukui M., Tanaka M., Toda H., Asano M., Yamazaki M., Hasegawa G., Imai S., Fujinami A., Ohta M., Nakamura N. The serum concentration of allograft inflammatory factor-1 is correlated with metabolic parameters in healthy subjects. Metabolism 2012, 61(7):1021-1025.
15. Gertig U., Hanisch U.K. Microglial diversity by responses and responders. Front. Cell. Neurosci. 2014, 8.
16. Graeber M.B. Changing Face of Microglia. Science 2010, 330(6005):783-788.
17. Griffiths M.R., Gasque P., Neal J.W. The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review. Int. J. Inflamm. 2010, 2010:151097.
18. Hinwood M., Morandini J., Day T.A., Walker F.R. Evidence that Microglia Mediate the Neurobiological Effects of Chronic Psychological Stress on the Medial Prefrontal Cortex. Cereb. Cortex 2012, 22(6):1442-1454.
19. Hsieh C.L., Koike M., Spusta S.C., Niemi E.C., Yenari M., Nakamura M.C., Seaman W.E. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J. Neurochem. 2009, 109(4):1144-1156.
20. Hughes V. The Constant Gardeners. Nature 2012, 485(7400):570-572.
21. Ito H., Hamerman J.A. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur. J. Immunol. 2012, 42(1):176-185.
22. Ivleva E.I., Morris D.W., Moates A.F., Suppes T., Thaker G.K., Tamminga C.A. Genetics and intermediate phenotypes of the schizophrenia-bipolar disorder boundary. Neurosci. Biobehav. Rev. 2010, 34(6):897-921.
23. Iwamoto K., Bundo M., Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 2005, 14(2):241-253.
24. Kerrien S., Aranda B., Breuza L., Bridge A., Broackes-Carter F., Chen C., Duesbury M., Dumousseau M., Feuermann M., Hinz U., Jandrasits C., Jimenez R.C., Khadake J., Mahadevan U., Masson P., Pedruzzi I., Pfeiffenberger E., Porras P., Raghunath A., Roechert B., Orchard S., Hermjakob H. The IntAct molecular interaction database in 2012. Nucleic Acids Res. 2012, 40(Database issue):D841-D846.
25. Keshava Prasad T.S., Goel R., Kandasamy K., Keerthikumar S., Kumar S., Mathivanan S., Telikicherla D., Raju R., Shafreen B., Venugopal A., Balakrishnan L., Marimuthu A., Banerjee S., Somanathan D.S., Sebastian A., Rani S., Ray S., Harrys Kishore C.J., Kanth S., Ahmed M., Kashyap M.K., Mohmood R., Ramachandra Y.L., Krishna V., Rahiman B.A., Mohan S., Ranganathan P., Ramabadran S., Chaerkady R., Pandey A. Human Protein Reference Database-2009 update. Nucleic Acids Res. 2009, 37(Database issue):D767-D772.
26. Kunz M., Cereser K.M., Goi P.D., Fries G.R., Teixeira A.L., Fernandes B.S., Belmonte-de-Abreu P.S., Kauer-Sant'Anna M., Kapczinski F., Gama C.S. Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev. Bras. Psiquiatr. 2011, 33(3):268-274.
27. Lampron A., Elali A., Rivest S. Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment. Neuron 2013, 78(2):214-232.
28. Lee S.A., Tsao T.T., Yang K.C., Lin H., Kuo Y.L., Hsu C.H., Lee W.K., Huang K.C., Kao C.Y. Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression. BMC Bioinforma. 2011, 12(Suppl. 13):S20.
29. Licata L., Briganti L., Peluso D., Perfetto L., Iannuccelli M., Galeota E., Sacco F., Palma A., Nardozza A.P., Santonico E., Castagnoli L., Cesareni G. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res. 2012, 40(Database issue):D857-D861.
30. Lichtenstein P., Yip B.H., Björk C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239.
31. Lin C.Y., Sawa A., Jaaro-Peled H. Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models. Neurobiol. Dis. 2012, 45(1):48-56.
32. Maier W., Zobel A., Wagner M. Schizophrenia and bipolar disorder: differences and overlaps. Curr. Opin. Psychiatry 2006, 19(2):165-170.
33. Marin-Teva J.L., Dusart I., Colin C., Gervais A., van Rooijen N., Mallat M. Microglia promote the death of developing Purkinje cells. Neuron 2004, 41(4):535-547.
34. McMahon F.J., Akula N., Schulze T.G., Muglia P., Tozzi F., Detera-Wadleigh S.D., Steele C.J., Breuer R., Strohmaier J., Wendland J.R., Mattheisen M., Muhleisen T.W., Maier W., Nothen M.M., Cichon S., Farmer A., Vincent J.B., Holsboer F., Preisig M., Rietschel M. Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat. Genet. 2010, 42(2):128-131.
35. Merikangas K.R., Akiskal H.S., Angst J., Greenberg P.E., Hirschfeld R.M., Petukhova M., Kessler R.C. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch. Gen. Psychiatry 2007, 64(5):543-552.
36. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70(7):663-671.
37. Monier A., Adle-Biassette H., Delezoide A.L., Evrard P., Gressens P., Verney C. Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex. J. Neuropathol. Exp. Neurol. 2007, 66(5):372-382.
38. Mosher K.I., Andres R.H., Fukuhara T., Bieri G., Hasegawa-Moriyama M., He Y., Guzman R., Wyss-Coray T. Neural progenitor cells regulate microglia functions and activity. Nat. Neurosci. 2012, 15(11):1485-1487.
39. Moskvina V., Craddock N., Holmans P., Nikolov I., Pahwa J.S., Green E., Owen M.J., O'Donovan M.C., Consortium, W.T.C.C. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol. Psychiatry 2009, 14(3):252-260.
40. Munkholm K., Vinberg M., Vedel Kessing L. Cytokines in bipolar disorder: a systematic review and meta-analysis. J. Affect. Disord. 2013, 144(1-2):16-27.
41. Najjar S., Pearlman D.M., Alper K., Najjar A., Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflammation 2013, 10:43.
42. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Möller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nöthen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R., Collaboration, M.G.o.S. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40(9):1053-1055.
43. Paradowska-Gorycka A., Jurkowska M. Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12. Hum. Immunol. 2013, 74(6):730-737.
44. Pedrini M., Massuda R., Fries G.R., Pasquali M.A.D., Schnorr C.E., Moreira J.C.F., Teixeira A.L., Lobato M.I.R., Walz J.C., Belmonte-de-Abreu P.S., Kauer-Sant'Anna M., Kapczinski F., Gama C.S. Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J. Psychiatr. Res. 2012, 46(6):819-824.
45. Rasmussen H.B., Timm S., Wang A.G., Soeby K., Lublin H., Fenger M., Hemmingsen R., Werge T. Association between the CCR5 32-bp deletion allele and late onset of schizophrenia. Am. J. Psychiatry 2006, 163(3):507-511.
46. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11(9):785-797.
47. Rovaris D.L., Mota N.R., Callegari-Jacques S.M., Bau C.H.D. Approaching "phantom heritability" in psychiatry by hypothesis-driven gene-gene interactions. Front. Hum. Neurosci. 2013, 7.
48. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. BioTech. 2003, 34(2):374-378.
49. Shao L., Vawter M.P. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol. Psychiatry 2008, 64(2):89-97.
50. Silva A.R., Grinberg L.T., Farfel J.M., Diniz B.S., Lima L.A., Silva P.J., Ferretti R.E., Rocha R.M., Filho W.J., Carraro D.M., Brentani H. Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer's disease. PLoS One 2012, 7(11):e48751.
51. Stertz L., Magalhaes P.V.S., Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr. Opin. Psychiatry 2013, 26(1):19-26.
52. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131(6):1164-1178.
53. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60(12):1187-1192.
54. Takahashi K., Rochford C.D.P., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 2005, 201(4):647-657.
55. Thrash J.C., Torbett B.E., Carson M.J. Developmental Regulation of TREM2 and DAP12 Expression in the Murine CNS: Implications for Nasu-Hakola Disease. Neurochem. Res. 2009, 34(1):38-45.
56. Torrey E.F. Community care and schizophrenia. Lancet 2000, 355(9217):1827-1828.
57. Williams H.J., Craddock N., Russo G., Hamshere M.L., Moskvina V., Dwyer S., Smith R.L., Green E., Grozeva D., Holmans P., Owen M.J., O'Donovan M.C. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum. Mol. Genet. 2011, 20(2):387-391.
58. Williams H.J., Norton N., Dwyer S., Moskvina V., Nikolov I., Carroll L., Georgieva L., Williams N.M., Morris D.W., Quinn E.M., Giegling I., Ikeda M., Wood J., Lencz T., Hultman C., Lichtenstein P., Thiselton D., Maher B.S., Malhotra A.K., Riley B., Kendler K.S., Gill M., Sullivan P., Sklar P., Purcell S., Nimgaonkar V.L., Kirov G., Holmans P., Corvin A., Rujescu D., Craddock N., Owen M.J., O'Donovan M.C., Molecular Genetics of Schizophrenia Collaboration (MGS), International Schizophrenia Consortium (ISC), S.G.E.-p, G.R.O.UP Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 2011, 16(4):429-441.
59. Wohleb E.S., Hanke M.L., Corona A.W., Powell N.D., Stiner L.M., Bailey M.T., Nelson R.J., Godbout J.P., Sheridan J.F. beta-Adrenergic Receptor Antagonism Prevents Anxiety-Like Behavior and Microglial Reactivity Induced by Repeated Social Defeat. J. Neurosci. 2011, 31(17):6277-6288.
60. Wohleb E.S., Fenn A.M., Pacenta A.M., Powell N.D., Sheridan J.F., Godbout J.P. Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology 2012, 37(9):1491-1505.
61. Zhang B., Kirov S., Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005, 33(Web Server issue):W741-W748.
62. Zhao Z., Xu J., Chen J., Kim S., Reimers M., Bacanu S.A., Yu H., Liu C., Sun J., Wang Q., Jia P., Xu F., Zhang Y., Kendler K.S., Peng Z., Chen X. Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol. Psychiatry 2014, 10.1038/mp.2014.82.